270. Chronic recurrent multifocal osteomyelitis Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 10 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 73
Chronic recurrent multifocal osteomyelitis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
270 | Chronic recurrent multifocal osteomyelitis | - |
46 | Malignant rheumatoid arthritis | 6.000 |
271 | Ankylosing spondylitis | 6.000 |
107 | Juvenile idiopathic arthritis | 6.000 |
50 | Dermatomyositis | 4.253 |
53 | Sjogren syndrome | 4.242 |
49 | Systemic lupus erythematosus | 4.203 |
13 | Multiple sclerosis/Neuromyelitis optica | 4.182 |
35 | Pemphigus | 2.909 |
40 | Takayasu arteritis | 2.880 |
285 | Fanconi anemia | 2.844 |
41 | Giant cell arteritis | 2.828 |
162 | Pemphigoid | 2.828 |
56 | Behcet disease | 2.815 |
60 | Aplastic anemia | 2.794 |
19 | Lysosomal storage disease | 2.744 |
65 | Primary immunodeficiency | 2.726 |
96 | Crohn disease | 2.698 |
55 | Relapsing polychondritis | 1.875 |
43 | Microscopic polyangiitis | 1.821 |
45 | Eosinophilic granulomatosis with Polyangiitis | 1.750 |
284 | Diamond-Blackfan anemia | 1.705 |
42 | Polyarteritis nodosa | 1.673 |
331 | Idiopathic multicentric castleman disease | 1.645 |
164 | Oculocutaneous albinism | 1.632 |
93 | Primary biliary cholangitis | 1.629 |
11 | Myasthenia gravis | 1.600 |
172 | Hypophosphatasia | 1.556 |
84 | Sarcoidosis | 1.555 |
34 | Neurofibromatosis | 1.552 |
51 | Scleroderma | 1.540 |
97 | Ulcerative colitis | 1.531 |
286 | Hereditary sideroblastic anemia | 1.000 |